Dexbrompheniramine maleate
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313426This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H19BrN2.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BPA9UT29BS, chemically known as 2-pyridinepropanamine, gamma-(4-bromophenyl)-n,n-dimethyl-, (s)-, (z)-2-butenedioate (1:1) but more generally known as dexbrompheniramine maleate, which bears US NIH Compound Identifier 6433334. European Medicines Agency schedules Dexbrompheniramine maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01626MIG. Most nations, for tariff and trade purposes, schedule dexbrompheniramine maleate under HS 29333999 and SITC 51574. As of Q4 2014, DEXBROMPHENIRAMINE MALEATE remains US FDA's Preferred Term for this commodity. Dexbrompheniramine maleate bears US NLM identifiers UMLS ID C0113291 and NCI Concept Code C61706. SMILES: CN(C)CC[C@@H](C1CCC(CC1)BR)C2CCCCN2.C(=C\C(=O)O)\C(=O)O.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.